Business & Finance
Amylin reportedly turns down Bristol's $3.5B acquisition bid
Bloomberg Mar. 28, 2012
Japanese firms announce details of biosimilar venture
PharmaTimes (U.K.) Mar. 28, 2012
RegeneRx signs term sheet with Lee's for peptide drugs
Genetic Engineering & Biotechnology News Mar. 27, 2012
Compugen forms subsidiary for mAb drug development
Genetic Engineering & Biotechnology News Mar. 28, 2012
Government & Legal News
AstraZeneca's antipsychotic Seroquel goes generic in U.S.
The Boston Globe Mar. 28, 2012, The Wall Street Journal Mar. 28, 2012
Horizon files suit against Par to protect Duexis patent
Reuters Mar. 28, 2012
FDA asks Chelsea for more evidence of Northera's efficacy
Reuters Mar. 28, 2012
FDA expands usage recommendations for antidepressant Celexa
U.S. News & World Report Mar. 28, 2012
Pipeline/R&D News
Targacept says compound works for asthma but not diabetes
The Wall Street Journal Mar. 27, 2012
Brodalumab and ixekizumab ease psoriasis in midstage trials
WebMD Mar. 28, 2012
Merck can proceed with Vytorin trial, safety panel says
The Wall Street Journal Mar. 28, 2012
Data analytics shed light on clinical-trial bottlenecks
Xconomy Mar. 27, 2012
